Alzheimer’s Disease & Related Dementias (ADRD)

Did you know?

Women’s health is an economic issue we can’t afford to ignore.

We Found:

If we invest $280 million in Alzheimer’s disease research focused on women, we get $930 million in returns to our economy.

We Learned:

Alzheimer’s disease research focused on women is more than good science, it’s a good investment, with a 224% return. Every dollar invested generates $3.24 in economic value and saves $1.24 in direct healthcare costs.

When we add $280 million for Alzheimer’s disease research focused on women, we get large returns:

years of life reclaimed
years with ADRD eliminated
years of nursing home care saved

Doubling funding for women’s ADRD research pays for itself 3x over.

Investing $300 million for women’s ADRD research adds back $930 million to our economy.

Research focused on women brings a 224% return on investment.

Read the WHAM Report Alzheimer’s Disease Brief:

WHAM Report Brief: Societal Impact of Research Funding for Women’s Health in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias

Without information on the potential return on investment for women’s health research, stakeholders lack a basis for altering research investments to improve knowledge of women’s health. In this report, the authors examine the societal cost impact of increasing research funding in Alzheimer’s disease and Alzheimer’s disease–related dementias and find that investing in women’s health research yields benefits beyond investing in general research.

Read the WHAM Report Alzheimer’s Disease Study Complete Technical Report:

Complete Technical WHAM Report: Societal Impact of Research Funding for Women’s Health in Alzheimer’s Disease

Stacy Pagos Haller, President and CEO, BrightFocus Foundation
Dr. Hadine Joffee, Founding Member and Lead Scientific Advisor to the WHAM Collaborative Executive Director, Mary Horrigan Connors Center for Women’s Health Research, Brigham and Women’s Hospital
Dr. Michelle Mielke, Associate Professor of Epidemiology and Neurology, Mayo Clinic Co-Director, Specialized Center for Research Excellence on Sex Differences, Mayo Clinic
Dr. Antonella Santuccione Chadha, PhD, Co-Founder, Women’s Brain Project Head Stakeholder Liaison, Alzheimer’s Disease, Biogen International Medical Manager, Alzheimer’s Disease, Roche Diagnostics Europe
Meryl Comer, Vice Chair and Global Chair, WHAM; Co-Founder, UsAgainstAlzheimers/ WomenAgainstAlzheimers; Chair, Global Alliance on Women’s Brain Health
JoAnn Manson, Michael and Lee Bell Professor of Women’s Health, Medicine, Harvard Medical School Co-Director, Women’s Health, Brigham and Women’s Hospital
Scroll to Top